Murine hippocampal neuronal culture characterization as a model for the study of NRGs/ErbB4 signaling

Main Article Content

Luis Felipe Monge-Mora
María Clara Soto Bernardini

Abstract

Neuregulins (NRGs) comprise a family of EGF-like growth factors that modulate diverse cellular responses by interacting with their receptors ErbBs. In the Central Nervous System (CNS) the principal members include NRG1 and NRG2, and their principal receptor is ErbB4. The NRG1/ErbB4 signaling has been involved in relevant processes for the development and maintenance of the CNS such as interneuron migration, myelinization, neurotransmission, and synapse modulation. NRG2 can also bind to ErbB4 and activate it. However, the NRG2/ErbB4 signaling remains less studied. There is evidence that functional disturbances in these signaling modules could lead to neuronal networks dysfunction. Therefore, a characterized in vitro model in terms of the neuronal population in which these proteins are expressed, and their gene expression is greatly important for the study of NRG/ErBb4 signaling. Here we determined an approximate proportion of 85% glutamatergic neurons and 15% GABAergic interneurons in hippocampal cultures, prepared from C57BL/6 mice in embryonic (E) day 18, similar to the proportion reported in the hippocampus in vivo. We also determined the expression of Nrg1 type III, Nrg2 and ErbB4 genes by the 7th day in vitro (DIV).  Nrg1 type III had higher expression levels than Nrg2. Together, these results suggest that these cultures can be used as a valid model for the study of NRGs signaling in vitro.

Article Details

How to Cite
Monge-Mora, L. F., & Soto Bernardini, M. C. (2021). Murine hippocampal neuronal culture characterization as a model for the study of NRGs/ErbB4 signaling. Tecnología En Marcha Journal, 35(1), Pág. 44–53. https://doi.org/10.18845/tm.v35i1.5429
Section
Artículo científico

References

L. Mei and K. A. Nave, “Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases,” Neuron, vol. 83, no. 1, pp. 27–49, 2014.

X. Liu et al., “Specific regulation of NRG1 isoform expression by neuronal activity,” J. Neurosci., vol. 31, no. 23, pp. 8491–8501, 2011.

J. Neddens and A. Buonanno, “Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice,” Hippocampus, vol. 20, no. 6, pp. 724–744, 2010.

M. Longart, Y. Liu, I. Karavanova, and A. Buonanno, “Neuregulin-2 is Developmentally Regulated and Targeted to Dendrites of Central Neurons,” J. Comp. Neurol., vol. 472, no. 2, pp. 156–172, 2004.

K. L. Carraway et al., “Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases,” Nature, vol. 387, no. 6632. pp. 512–516, 1997.

C. S. Crovello, C. Lai, L. C. Cantley, and K. L. Carraway, “Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2,” J. Biol. Chem., vol. 273, no. 41, pp. 26954–26961, 1998.

D. Vullhorst et al., “A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling,” Nat. Commun., vol. 6, no. June, 2015.

K. H. Lee et al., “Bidirectional signaling of neuregulin-2 mediates formation of GABAergic synapses and maturation of glutamatergic synapses in newborn granule cells of postnatal hippocampus,” J. Neurosci., vol. 35, no. 50, pp. 16479–16493, 2015.

I. Del Pino et al., “Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes,” Neuron, vol. 79, no. 6, pp. 1152–1168, 2013.

L. Yan et al., “Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders,” Nat. Publ. Gr., vol. 23, no. 5, pp. 1233–1243, 2018.

L. Athanasiu, M. Mattingsdal, A. K. Kähler, and A. Brown, “Europe PMC Funders Group Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort,” vol. 44, no. 12, pp. 748–753, 2011.

D. Li, D. A. Collier, and L. He, “Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia,” Hum. Mol. Genet., vol. 15, no. 12, pp. 1995–2002, 2006.

M. R. Munafò, D. L. Thiselton, T. G. Clark, and J. Flint, “Association of the NRG1 gene and schizophrenia: A meta-analysis,” Mol. Psychiatry, vol. 11, no. 6, pp. 539–546, 2006.

N. Norton et al., “Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia,” Am. J. Med. Genet. - Neuropsychiatr. Genet., vol. 141 B, no. 1, pp. 96–101, 2006.

H. Stefansson et al., “Neuregulin 1 and Susceptibility to Schizophrenia,” Am. J. Hum. Genet., vol. 71, no. 4, pp. 877–892, 2002.

C. Walss-Bass et al., “A Novel Missense Mutation in the Transmembrane Domain of Neuregulin 1 is Associated with Schizophrenia,” Biol. Psychiatry, vol. 60, no. 6, pp. 548–553, 2006.

I. Benzel et al., “Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia,” Behav. Brain Funct., vol. 3, pp. 1–11, 2007.

D. Vullhorst and A. Buonanno, “NMDA Receptors Regulate Neuregulin 2 Binding to ER-PM Junctions and Ectodomain Release,” Mol. Neurobiol., vol. 56, no. 12, pp. 8345–8363, 2019.

A. Garrido-García et al., “Neurogranin Expression Is Regulated by Synaptic Activity and Promotes Synaptogenesis in Cultured Hippocampal Neurons,” Mol. Neurobiol., vol. 56, no. 11, pp. 7321–7337, 2019.

P. Fazzari et al., “Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling,” Nature, vol. 464, no. 7293, pp. 1376–1380, 2010.

K. M. Gerecke, J. M. Wyss, and S. L. Carroll, “Neuregulin-1 B induces neurite extension and arborization in cultured hippocampal neurons,” vol. 27, pp. 379–393, 2004.

T. Xu, P. Molnar, C. Gregory, M. Das, T. Boland, and J. J. Hickman, “Electrophysiological characterization of embryonic hippocampal neurons cultured in a 3D collagen hydrogel,” Biomaterials, vol. 30, no. 26, pp. 4377–4383, 2009.

R. I. Freshney, Culture of Animal Cells: a manual of basic technique and specialized applications, 6th ed. United Kingdom: Wiley-Blackwell, 2010.

L. Mei and W. C. Xiong, “Neuregulin 1 in neural development, synaptic plasticity and schizophrenia,” Nat. Rev. Neurosci., vol. 9, no. 6, pp. 437–452, 2008.

D. L. Falls, “Neuregulins: Functions, forms, and signaling strategies,” EGF Recept. Fam. Biol. Mech. Role Cancer, vol. 284, pp. 15–31, 2003.

H. Markram, M. Toledo-Rodriguez, Y. Wang, A. Gupta, G. Silberberg, and C. Wu, “Interneurons of the neocortical inhibitory system,” Nat. Rev. Neurosci., vol. 5, no. 10, pp. 793–807, 2004.

J. G. Allison, P. M. Das, J. Ma, F. M. Inglis, and F. E. Jones, “The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons,” Neurosci. Res., vol. 70, no. 2, pp. 155–163, 2011.